Penumbra, Inc.

New Capabilities

Received FDA clearance for its Lightning CAVT system for deep vein thrombosis

Four late-breaking trials at The VEINS 2026 conference in Las Vegas reported results for catheter-based venous disease treatments. They covered iliac vein stenting for post-thrombotic syndrome, single-session mechanical thrombectomy for deep vein thrombosis, cyanoacrylate closure for venous leg ulcers, and an interim look at a pulmonary embolism device.

Updated Oct 22